While a necessary administrative tool, the current retrospective medication prior authorization (PA) process is known for its complexity, frustration, inefficiency and costliness. For payers, it can increase operational costs, burden clinical resources, and can negatively impact their relationship with providers and members.
By participating attendees will learn :
Who should attend: Health plans with medication prior authorization programs
Ryan Hess, VP Product Innovation, Surescripts
Ryan Hess, Vice President of Product Innovation. Ryan manages multiple businesses for Surescripts, including the Medication History
portfolio of services, CompletEPA, Medication Management for Adherence, and our Specialty services. Ryan has been with Surescripts for 4 years.
Ryan joined Surescripts from Bain & Co, a management consulting firm, where he was a Principal. He spent nine years at Bain, primarily working in the healthcare industry. Ryan holds an MBA from the Darden School of Business (University of Virginia) and a BA in Economics / BS in Mathematics from Boston College. Ryan lives with his wife Susan in McLean, VA.